Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 103.30
Change Today 0.00 / 0.00%
Volume 0.0
BICL On Other Exchanges
Symbol
Exchange
OTC US
Tel Aviv
As of 10:24 AM 05/21/15 All times are local (Market data is delayed by at least 15 minutes).

biocancell ltd (BICL) Snapshot

Open
$103.60
Previous Close
$101.70
Day High
$103.70
Day Low
$102.40
52 Week High
05/27/14 - $261.18
52 Week Low
04/19/15 - $91.40
Market Cap
50.5M
Average Volume 10 Days
44.9K
EPS TTM
$-0.89
Shares Outstanding
48.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOCANCELL LTD (BICL)

Related News

No related news articles were found.

biocancell ltd (BICL) Related Businessweek News

No Related Businessweek News Found

biocancell ltd (BICL) Details

BioCancell Ltd., a biotechnology research and development company, develops drugs for treating various types of cancer. Its lead drug-candidate is BC-819, which is used for the treatment of bladder cancer. The company was founded in 2004 and is based in Jerusalem, Israel. BioCancell Ltd. is a subsidiary of Clal Biotechnology Industries Ltd.

Founded in 2004

biocancell ltd (BICL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

biocancell ltd (BICL) Key Developments

BioCancell Ltd., Annual General Meeting, May 06, 2015

BioCancell Ltd., Annual General Meeting, May 06, 2015., at 11:00 Israel Standard Time.

BioCancell Ltd., Special/Extraordinary Shareholders Meeting, Apr 15, 2015

BioCancell Ltd., Special/Extraordinary Shareholders Meeting, Apr 15, 2015., at 11:00 Israel Standard Time.

BioCancell Ltd. Auditor Raises 'Going Concern' Doubt

BioCancell Ltd. filed its Annual on Feb 22, 2015 for the period ending Dec 31, 2014. In this report its auditor, Somekh Chaikin, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BICL:IT 103.30 0.00

BICL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BICL.
View Industry Companies
 

Industry Analysis

BICL

Industry Average

Valuation BICL Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOCANCELL LTD, please visit www.biocancell.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.